Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Abstract 1911: ΔNp63α promotes TGFβ-induced metastasis by silencing a microRNA network restraining wound healing

Lidia Rodriguez Calleja, camille Jacques, Francois Lamoureux, Marc Baud’huin, Thibault Quillard, Franck Verrecchia, Dominique Heymann, Leif Ellisen, Benjamin Ory

Cancer Res (2016) 76 (14_Supplement): 1911.

https://doi.org/10.1158/1538-7445.AM2016-1911

Published: 15 July 2016

View article titled, Abstract 1911: ΔNp63α promotes TGFβ-induced metastasis by silencing a microRNA network restraining wound healing

Journal Articles

Abstract 4270: UMR957: a new osteogenic osteosarcoma cell-line derived from an osteoprotegerin null mutant mouse

Benjamin Navet, Jérome Amiaud, Céline Charrier, Thibaut Quillard, Bénédicte Brounais-Le Royer, Dominique Heymann, Frederic P.R. Lezot.

Cancer Res (2016) 76 (14_Supplement): 4270.

https://doi.org/10.1158/1538-7445.AM2016-4270

Published: 15 July 2016

View article titled, Abstract 4270: UMR957: a new osteogenic osteosarcoma cell-line derived from an osteoprotegerin null mutant mouse

Journal Articles

Abstract 4472: Targeting the oncogenic transcription factor EWS-Fli1 by BET bromodomain inhibition in Ewing sarcoma

Camille JACQUES, François LAMOUREUX, Marc BAUD’HUIN, Lidia RODRIGUEZ-CALLEJA, Thibaut QUILLARD, Pierre PERROT, Franck TIRODE, Françoise REDINI, James E. BRADNER, Dominique HEYMANN, Benjamin ORY

Cancer Res (2016) 76 (14_Supplement): 4472.

https://doi.org/10.1158/1538-7445.AM2016-4472

Published: 15 July 2016

View article titled, Abstract 4472: Targeting the oncogenic transcription factor EWS-Fli1 by BET bromodomain inhibition in Ewing sarcoma

Journal Articles

ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis

Lidia Rodriguez Calleja, Camille Jacques, François Lamoureux, Marc Baud'huin, Marta Tellez Gabriel, Thibaut Quillard, Debashish Sahay, Pierre Perrot, Jerome Amiaud, Celine Charrier, Regis Brion, Fernando Lecanda, Franck Verrecchia, Dominique Heymann, Leif W. Ellisen, Benjamin Ory

Cancer Res (2016) 76 (11): 3236–3251.

https://doi.org/10.1158/0008-5472.CAN-15-2317

Published: 31 May 2016

View article titled, ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis

Includes: Supplementary data

Journal Articles

Abstract B46: miRNA-193a-5p repression of p73 induces Cisplatine chemoresistance in bone-related sarcomas

Camille Jacques, François Lamoureux, Marc Baud'huin, Lidia Rodriguez Calleja, Dominique Heymann, Benjamin Ory

Cancer Res (2016) 76 (6_Supplement): B46.

https://doi.org/10.1158/1538-7445.NONRNA15-B46

Published: 13 May 2016

View article titled, Abstract B46: miRNA-193a-5p repression of p73 induces Cisplatine chemoresistance in bone-related sarcomas

Journal Articles

Abstract 1439: RANK expression by osteosarcoma cells increases lung metastasis in Nude mouse while has no effect in immune-competent mouse

Benjamin Navet, Kosei Ando, Hideo Yagita, Christopher G. Mueller, Dominique Heymann, Frederic Lezot

Cancer Res (2015) 75 (15_Supplement): 1439.

https://doi.org/10.1158/1538-7445.AM2015-1439

Published: 01 August 2015

View article titled, Abstract 1439: RANK expression by osteosarcoma cells increases lung metastasis in Nude mouse while has no effect in immune-competent mouse

Journal Articles

Abstract 1750: Preclinical efficacy of Hsp90 inhibition by using PF-04942847 in osteosarcoma

Marc Baud'Huin, Benjamin Ory, Franck Verrecchia, Dominique Heymann, Francoise Redini, Francois Lamoureux

Cancer Res (2015) 75 (15_Supplement): 1750.

https://doi.org/10.1158/1538-7445.AM2015-1750

Published: 01 August 2015

View article titled, Abstract 1750: Preclinical efficacy of Hsp90 inhibition by using PF-04942847 in osteosarcoma

Journal Articles

Abstract 3289: Skeletal consequences of bone resorption inhibitors (zoledronic acid and RANKL blocking antibody) injections during growth: mouse strain disparities and synergic effect

Frederic P. Lezot, Benjamin Navet, YongWon Choi, Hideo Yagita, Ariane Berdal, Christopher G. Mueller, Francoise Redini, Dominique Heymann

Cancer Res (2015) 75 (15_Supplement): 3289.

https://doi.org/10.1158/1538-7445.AM2015-3289

Published: 01 August 2015

View article titled, Abstract 3289: Skeletal consequences of bone resorption inhibitors (zoledronic acid and RANKL blocking antibody) injections during growth: mouse strain disparities and synergic effect

Journal Articles

Abstract A50: Selective inhibition of BET bromodomains epigenetic signaling interferes with the bone-associated tumor vicious cycle

Francois Lamoureux, Marc Baud'huin, Lidia Rodriguez, Camille Jacques, Francoise Redini, James E. Bradner, Dominique Heymann, Benjamin Ory

Cancer Res (2014) 74 (20_Supplement): A50.

https://doi.org/10.1158/1538-7445.PEDCAN-A50

Published: 09 October 2014

View article titled, Abstract A50: Selective inhibition of BET bromodomains epigenetic signaling interferes with the bone-associated tumor vicious cycle

Journal Articles

Abstract LB-142: Selective inhibition of BET bromodomains epigenetic signaling interferes with the bone-associated tumor vicious cycle

Francois Lamoureux, Marc Baud'Huin, Lidia Rodriguez Calleja, Camille Jacques, Francoise Redini, James E. Bradner, Dominique Heymann, Benjamin Ory

Cancer Res (2014) 74 (19_Supplement): LB-142.

https://doi.org/10.1158/1538-7445.AM2014-LB-142

Published: 01 October 2014

View article titled, Abstract LB-142: Selective inhibition of BET bromodomains epigenetic signaling interferes with the bone-associated tumor vicious cycle

Journal Articles

Abstract B53: Selective BET bromodomains epigenetic signaling inhibition as a therapeutic strategy in primary bone tumors

Francois Lamoureux, Marc Baud'huin, Lidia Rodriguez, Camille Jacques, Martine Berreur, Francoise Rédini, James E. Bradner, Dominique Heymann, Benjamin Ory

Cancer Res (2013) 73 (13_Supplement): B53.

https://doi.org/10.1158/1538-7445.CEC13-B53

Published: 13 May 2014

View article titled, Abstract B53: Selective BET bromodomains epigenetic signaling inhibition as a therapeutic strategy in primary bone tumors

Journal Articles

Zoledronic Acid Potentiates mTOR Inhibition and Abolishes the Resistance of Osteosarcoma Cells to RAD001 (Everolimus): Pivotal Role of the Prenylation Process

Gatien Moriceau, Benjamin Ory, Laura Mitrofan, Chiara Riganti, Frédéric Blanchard, Régis Brion, Céline Charrier, Séverine Battaglia, Paul Pilet, Marc G. Denis, Leonard D. Shultz, Jukka Mönkkönen, Françoise Rédini, Dominique Heymann

Cancer Res (2010) 70 (24): 10329–10339.

https://doi.org/10.1158/0008-5472.CAN-10-0578

Published: 14 December 2010

View article titled, Zoledronic Acid Potentiates mTOR Inhibition and Abolishes the Resistance of Osteosarcoma Cells to RAD001 (Everolimus): Pivotal Role of the Prenylation Process

Includes: Supplementary data

Journal Articles

Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients

Guillaume A. Odri, Sophie Dumoucel, Gaëlle Picarda, Séverine Battaglia, François Lamoureux, Nadège Corradini, Julie Rousseau, Franck Tirode, Karine Laud, Olivier Delattre, François Gouin, Dominique Heymann, Françoise Redini

Cancer Res (2010) 70 (19): 7610–7619.

https://doi.org/10.1158/0008-5472.CAN-09-4272

Published: 29 September 2010

View article titled, Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients

Includes: Supplementary data

Journal Articles

Glycosaminoglycans as Potential Regulators of Osteoprotegerin Therapeutic Activity in Osteosarcoma

Francois Lamoureux, Gaëlle Picarda, Laure Garrigue-Antar, Marc Baud'huin, Valerie Trichet, André Vidal, Elisabeth Miot-Noirault, Bruno Pitard, Dominique Heymann, Françoise Rédini

Cancer Res (2009) 69 (2): 526–536.

https://doi.org/10.1158/0008-5472.CAN-08-2648

Published: 15 January 2009

View article titled, Glycosaminoglycans as Potential Regulators of Osteoprotegerin Therapeutic Activity in Osteosarcoma

Journal Articles

Killer Dendritic Cells Link Innate and Adaptive Immunity against Established Osteosarcoma in Rats

Camille Chauvin, Jean-Marie Philippeau, Caroline Hémont, Francois-Xavier Hubert, Yohann Wittrant, Francois Lamoureux, Benjamin Trinité, Dominique Heymann, Françoise Rédini, Régis Josien

Cancer Res (2008) 68 (22): 9433–9440.

https://doi.org/10.1158/0008-5472.CAN-08-0104

Published: 14 November 2008

View article titled, Killer Dendritic Cells Link Innate and Adaptive Immunity against Established Osteosarcoma in Rats

Journal Articles

Therapeutic Relevance of Osteoprotegerin Gene Therapy in Osteosarcoma: Blockade of the Vicious Cycle between Tumor Cell Proliferation and Bone Resorption

François Lamoureux, Peggy Richard, Yohann Wittrant, Séverine Battaglia, Paul Pilet, Valérie Trichet, Frédéric Blanchard, François Gouin, Bruno Pitard, Dominique Heymann, Françoise Redini

Cancer Res (2007) 67 (15): 7308–7318.

https://doi.org/10.1158/0008-5472.CAN-06-4130

Published: 01 August 2007

View article titled, Therapeutic Relevance of Osteoprotegerin Gene Therapy in Osteosarcoma: Blockade of the Vicious Cycle between Tumor Cell Proliferation and Bone Resorption

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 1911: ΔNp63α promotes TGFβ-induced metastasis by silencing a microRNA network restraining wound healing

Abstract 4270: UMR957: a new osteogenic osteosarcoma cell-line derived from an osteoprotegerin null mutant mouse

Abstract 4472: Targeting the oncogenic transcription factor EWS-Fli1 by BET bromodomain inhibition in Ewing sarcoma

ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis

Abstract B46: miRNA-193a-5p repression of p73 induces Cisplatine chemoresistance in bone-related sarcomas

Abstract 1439: RANK expression by osteosarcoma cells increases lung metastasis in Nude mouse while has no effect in immune-competent mouse

Abstract 1750: Preclinical efficacy of Hsp90 inhibition by using PF-04942847 in osteosarcoma

Abstract 3289: Skeletal consequences of bone resorption inhibitors (zoledronic acid and RANKL blocking antibody) injections during growth: mouse strain disparities and synergic effect

Abstract A50: Selective inhibition of BET bromodomains epigenetic signaling interferes with the bone-associated tumor vicious cycle

Abstract LB-142: Selective inhibition of BET bromodomains epigenetic signaling interferes with the bone-associated tumor vicious cycle

Abstract B53: Selective BET bromodomains epigenetic signaling inhibition as a therapeutic strategy in primary bone tumors

Zoledronic Acid Potentiates mTOR Inhibition and Abolishes the Resistance of Osteosarcoma Cells to RAD001 (Everolimus): Pivotal Role of the Prenylation Process

Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients

Glycosaminoglycans as Potential Regulators of Osteoprotegerin Therapeutic Activity in Osteosarcoma

Killer Dendritic Cells Link Innate and Adaptive Immunity against Established Osteosarcoma in Rats

Therapeutic Relevance of Osteoprotegerin Gene Therapy in Osteosarcoma: Blockade of the Vicious Cycle between Tumor Cell Proliferation and Bone Resorption

Email alerts

AACR Journals

Resources

AACR Journals
on Social Media

Update search

Email alerts

AACR Journals

Resources

AACR Journals on Social Media

This Feature Is Available To Subscribers Only

AACR Journals
on Social Media